About the speaker: John Mastrototaro is the CEO of Movano Health and a seasoned medical device executive specializing in strategy, research, and technology development. With a history at Medtronic and Orthofix, he pioneered innovations like continuous glucose monitoring and the first artificial pancreas, achieving over 65% global market share in diabetes care. John is a visionary leader advancing patient care through groundbreaking technologies.

About the company: Movano Inc. develops innovative, wearable medical devices that deliver medical-grade accuracy. Founded in 2018, Movano Health provides high-quality data and personalized insights, empowering consumers to take control of their health. Their devices capture vital health information, fostering proactive health management for individuals, caretakers, and healthcare professionals.

Revenue: 5M USD

Employees: 50+